First New York Securities’s Ambit Biosciences Corp AMBI Stock Holding History
Bought
Maintained
Sold
First New York Securities's AMBI Position: Q4 2014 in Review
First New York Securities sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 3,000 shares — an estimated $46.2K sold.
First New York Securities first reported a position in AMBI in Q3 2014 and held it in 1 quarter. The position peaked at $46.2K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.
- First New York Securities reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
- First New York Securities sold 3,000 Ambit Biosciences Corp shares in Q4 2014, an estimated $46.2K.
- First New York Securities first reported a position in Ambit Biosciences Corp in Q3 2014 and held it in 1 quarter.
- First New York Securities's Ambit Biosciences Corp position peaked at $46.2K in Q3 2014.
- 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.
Based on First New York Securities's 13F filing for Q4 2014, filed 9 Jan 2015.